Clinical Trials Logo

Respiration Disorders clinical trials

View clinical trials related to Respiration Disorders.

Filter by:

NCT ID: NCT04623762 Completed - Clinical trials for Chronic Respiratory Disease

Yoga On Dyspnea, Sleep And Fatıgue In Chronıc Respıratory Dıseases

Start date: May 1, 2020
Phase: N/A
Study type: Interventional

Although there are a limited number of studies in the literature investigating the effect of yoga on dyspnea, quality of life and respiratory functions of chronic respiratory patients There is no study examining the effect of yoga on sleep and fatigue of chronic respiratory patients. Therefore, this study was conducted to determine the effect of yoga on dyspnea, sleep, and fatigue applied to chronic respiratory patients.

NCT ID: NCT04619680 Completed - Clinical trials for Interstitial Lung Disease

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

ENDCOV-I
Start date: November 18, 2020
Phase: Phase 4
Study type: Interventional

This is a collaborative study between Icahn School of Medicine at Mount Sinai, Boehringer Ingelheim Pharmaceuticals and up to 9 other clinical centers across the US to determine the effect of nintedanib on slowing the rate of lung disease in patients who have been diagnosed with COVID-19, and have ongoing lung injury more than 30 days out from their diagnosis. Required one of the following after diagnosis with SARS-CoV-2: supplemental oxygen by nasal cannula, high flow oxygen, non invasive ventilation such as CPAP or BIPAP, or mechanical ventilation or a history of desaturation below 90%.

NCT ID: NCT04607330 Completed - Stroke Clinical Trials

Protein Top-up Acceptability Study for Patients With Increased Protein Needs

Start date: October 28, 2020
Phase: N/A
Study type: Interventional

The aim of this prospective, single-arm intervention study is to evaluate the acceptability (compliance, gastrointestinal tolerance, and palatability) to a low calorie, low volume, ready to use, high protein liquid in patients with elevated protein needs.

NCT ID: NCT04606407 Completed - Covid19 Clinical Trials

Inhaled NO for the Treatment of Viral Pneumonia in Adults

Start date: November 25, 2020
Phase: N/A
Study type: Interventional

The purpose of this multi center, open label, randomized, study is to obtain information on the safety and efficacy of 150 ppm Nitric Oxide given in addition to the standard of care of patients with viral pneumonia

NCT ID: NCT04598659 Completed - Stroke Clinical Trials

Nene Remote Monitoring Proof of Concept

Start date: January 6, 2021
Phase:
Study type: Observational

This feasibility study is being conducted to investigate the practicalities and potential benefits of equipping patients with wearable monitoring devices.

NCT ID: NCT04581096 Completed - Covid19 Clinical Trials

Mapping COVID-19 Spread in a Tertiary Hospital

MEDyMAP
Start date: October 2, 2020
Phase:
Study type: Observational [Patient Registry]

One of the major problems in suppressing the spreading of an epidemic resides in understanding and monitoring its propagation patterns, and in evaluating how these are modified by enforced policies. The standard solution requires detailed information at the microscopic scales, e.g. how infected people have moved and whom they came in contact with, which is hardly ever available. The researchers propose a novel approach to the study of the propagation of COVID-19, in which a proxy of this information is derived at macroscopic scales. This will be based on two ingredients: the spatiotemporal study in shiny with mathematical models with aggregated or non aggregated data and the reconstruction of functional networks of spreading patterns, and the development of a supporting software.

NCT ID: NCT04482231 Completed - Clinical trials for Antibiotic Sore Tongue

Antibiotic Observatory for Respiratory Diseases, Apart From Tuberculosis and Reportable Diseases

AORD
Start date: January 2, 2018
Phase:
Study type: Observational [Patient Registry]

the study aimed to determine the distribution of respiratory infections in Tunisian population and evaluate the frequency of antibiotics prescribed according to current international recommendations.

NCT ID: NCT04467190 Completed - Respiratory Disease Clinical Trials

Investigation of Inflammacheck to Measure Exhaled Breath Condensate Hydrogen Peroxide in Respiratory Conditions

VICTORY
Start date: September 13, 2019
Phase:
Study type: Observational

People with lung conditions can suffer significantly with their symptoms and often require multiple trips to their GP or secondary care before a diagnosis is made. It can be difficult to diagnose lung disease and to differentiate between different lung conditions, so many people may be misdiagnosed or incorrectly not given a diagnosis. The tests currently used to diagnose lung diseases can be difficult or uncomfortable to do, especially if the person is experiencing lots of symptoms, and therefore can give poor or unreliable results.A new quick and easy to perform test is needed that can differentiate between various lung conditions and people with no lung disease, that can be performed in primary and secondary care with immediate results.

NCT ID: NCT04413292 Completed - Clinical trials for Bronchial Neoplasm Benign

Survivin and Fibulin-3 in Benign and Malignant Respiratory Diseases

Start date: January 1, 2017
Phase:
Study type: Observational

Purpose: Survivin is a common member of the inhibitors of the apoptosis protein (IAP) family with a dual role in promoting cell proliferation and preventing apoptosis. Fibulin-3, a matrix glycoprotein, was recently presented as a promising novel biomarker for malignant pleural mesothelioma. The aim of this study was to validate the expression levels of survivin and fibulin-3 in benign and malignant respiratory diseases. Patients and methods: The study included 73 patients, with various benign and malignant respiratory diseases. For validation of the data, a control group including 20 healthy subjects was chosen. The clinical and radiological assessments of the included individuals were done. The serum survivin and fibulin-3 levels were measured using ELISA assays kits, while their local expressions in the lung and pleura were assessed using western blot analysis.

NCT ID: NCT04407806 Completed - Asthma in Children Clinical Trials

Utility of Continuous Pulse Oximetry for Pediatric Patients With Stable Respiratory Illness

Start date: December 24, 2020
Phase: N/A
Study type: Interventional

This is a randomized, prospective study to determine if there is a difference in hospital length of stay between patients receiving continuous hardwire cardiorespiratory monitoring and those receiving intermittent vital signs measurements among pediatric patients admitted for uncomplicated respiratory illness.